tadalafil has been researched along with Heart Failure, Diastolic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnett, JC; Chen, HH; Hodge, DO; McKie, PM; Slusser, JP; Wan, SH | 1 |
| Faria, AP; Modolo, R; Moreno, BV; Moreno, H | 1 |
1 review(s) available for tadalafil and Heart Failure, Diastolic
| Article | Year |
|---|---|
Effects of PDE type 5 inhibitors on left ventricular diastolic dysfunction in resistant hypertension.
Topics: Carbolines; Diastole; Drug Resistance; Heart Failure, Diastolic; Humans; Hypertension; Medical Illustration; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Tadalafil; Treatment Outcome; Ventricular Dysfunction, Left | 2015 |
1 trial(s) available for tadalafil and Heart Failure, Diastolic
| Article | Year |
|---|---|
Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction.
Topics: Aged; Aged, 80 and over; Cyclic GMP; Drug Combinations; Female; Glomerular Filtration Rate; Heart Failure, Diastolic; Humans; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Phosphodiesterase 5 Inhibitors; Renal Elimination; Tadalafil | 2021 |